D. Lattuada et al., MONOCLONAL-ANTIBODIES AGAINST RECOMBINANT HUMAN GROWTH-HORMONE AS PROBES TO STUDY IMMUNE FUNCTION, Hybridoma, 15(3), 1996, pp. 211-217
Monoclonal antibodies were raised against human recombinant growth hor
mone (rhGH) and those that did not cross-react with other human recomb
inant proteins like prolactin (PRL), interleukin 2 (IL-2), insulin, or
bovine pituitary growth hormone were selected, The selected hybridoma
supernatants were studied for their ability to influence T lymphocyte
proliferation when induced either by a mitogen, such as phytohemagglu
tinin (PHA), or by alloantigen, All supernatants inhibited proliferati
on, Three MAbs were then purified by several passages on antimouse IgG
(or IgM)-agarose columns, and characterized, These MAbs recognized th
ree different epitopes, as revealed by competition study, although the
ir inhibitory effect on PHA-induced T cell proliferation was quite sim
ilar, The data demonstrate that the MAbs were not cytolytic, that they
did not interfere with the PHA binding to T cell membranes, and, as r
evealed by FAGS analysis, did not bind to the membrane, Finally, these
MAbs immunoprecipitated a 44-kDa molecule from PHA-activated T cell-c
oncentrated supernatants. These data indicate that the MAbs recognized
a soluble factor that plays a central role in T cell proliferation an
d that is probably the immune growth hormone.